The lab is committed to advancing care for patients with kidney disease by integrating both quantitative and qualitative research methodologies. Our group employs a multifaceted approach, harnessing the strengths of data science, epidemiology, and social science to drive better outcomes for those affected by kidney disease. The research has been supported by the American Philosophical Society, the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant, and the BU DOM Research Accelerator Program.
Five selected publications:
1. M. Wittig, A. Verma, A. Bellavia, S. Rosan, S.E. Claudel, A. Surapaneni, R. Palsson, A. Srivastava, I.E. Stillman, J.M. Henderson, L.H. Beck Jr., J.B. Hodgin, M.E. Grams, E.P. Rhee, T.B. Huber, S.S. Waikar, I.M. Schmidt. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression, Kidney360 (2025), accepted for publication
2. Schmidt IM, Surapaneni AL, Zhao R, Upadhyay D, Yeo WJ, Schlosser P, Huynh C, Srivastava A, Palsson R, Kim T, Stillman IE, Barwinska D, Barasch J, Eadon MT, El-Achkar TM, Henderson J, Moledina DG, Rosas SE, Claudel SE, Verma A, Wen Y, Lindenmayer M, Huber TB, Parikh SV, Shapiro JP, Rovin BH, Stanaway IB, Sathe NA, Bhatraju PK, Coresh J; KPMP; Rhee EP, Grams ME, Waikar SS. Plasma Proteomics of Acute Tubular Injury. Nature Communications (2024) PMID: 39191768
3. M. Shohet, L. Stern, N. Nguyen, S.S. Waikar, I.M. Schmidt. Structural and Psychosocial Challenges Among Underserved Patients Receiving Hemodialysis During and Beyond the Coronavirus Disease 2019 Pandemic: A Qualitative Study, Kidney Medicine (2023), DOI: 10.1016/74 j.xkme.2023.100717
4. Schmidt IM, Myrick S, Liu J, Verma A, Srivastava A, Palsson R, Onul IF, Stillman IE, Patil P, Waikar SS. The Use of Plasma Biomarker-derived Clusters for Clinicopathologic Phenotyping: Results from The Boston Kidney Biopsy Cohort, Clinical Kidney Journal (2022), PMID: 36726432; PMCID: PMC9871860.
5. Schmidt IM, Colona MR, Kestenbaum BR, Alexopoulos LG, Palsson R, Srivastava A, Liu J, Stillman IE, Rennke HG, Vaidya VS, Wu H, Humphreys BD, Waikar SS. CDH11, SMOC2, and PEDF are promising non-invasive biomarkers of kidney fibrosis. Kidney International (2021), PMID: 34051265